| Tiempos para la revascularización multivaso en pacientes estables con IAMCEST: revisión sistemática y metanálisis en red F Voll, C Kuna, M Scalamogna, T Kessler, S Kufner, T Rheude, HB Sager, ... Revista Española de Cardiología, 2024 | | 2024 |
| Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third … G Ndrepepa, S Cassese, E Xhepa, M Joner, HB Sager, S Kufner, ... Clinical Research in Cardiology 113 (7), 1006-1016, 2024 | | 2024 |
| Modified balloons to prepare severely calcified coronary lesions before stent implantation: a systematic review and meta-analysis of randomized trials M Scalamogna, C Kuna, F Voll, A Aytekin, S Lahu, T Kessler, S Kufner, ... Clinical Research in Cardiology 113 (7), 995-1005, 2024 | 5 | 2024 |
| Timing of multivessel revascularization in stable patients with STEMI: a systematic review and network meta-analysis F Voll, C Kuna, M Scalamogna, T Kessler, S Kufner, T Rheude, HB Sager, ... Revista Española de Cardiología (English Edition), 2024 | | 2024 |
| Aspirin loading and coronary no‐reflow after percutaneous coronary intervention in patients with acute myocardial infarction G Ndrepepa, S Cassese, E Xhepa, M Joner, HB Sager, S Kufner, ... European Journal of Clinical Investigation 54 (6), e14173, 2024 | | 2024 |
| Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel A Aytekin, M Scalamogna, JJ Coughlan, S Lahu, G Ndrepepa, ... Clinical Research in Cardiology, 1-10, 2024 | | 2024 |
| Percutaneous Coronary Intervention in Nonagenarians Presenting With an Acute Coronary Syndrome G Ndrepepa American Journal of Cardiology 216, 108-109, 2024 | | 2024 |
| A Ten-Year Follow-Up Study of the Association Between Uric Acid and Adverse Cardiovascular Events in Patients With Coronary Artery Disease G Ndrepepa, S Kufner, S Cassese, M Joner, E Xhepa, J Wiebe, HB Sager, ... The American Journal of Cardiology 216, 19-26, 2024 | 1 | 2024 |
| Plasma soluble glycoprotein VI, platelet function, bleeding, and ischemic events in patients undergoing elective percutaneous coronary intervention S Lahu, K Adler, K Mayer, R Hein-Rothweiler, I Bernlochner, G Ndrepepa, ... Thrombosis and Haemostasis 124 (04), 297-306, 2024 | 3 | 2024 |
| Incidence and pattern of repeat coronary revascularizations in patients with acute coronary syndromes treated with ticagrelor or prasugrel A Aytekin, M Scalamogna, JJ Coughlan, S Lahu, G Ndrepepa, ... European Heart Journal 44 (Supplement_2), ehad655. 1472, 2023 | | 2023 |
| SYNTAX Score and Outcomes in Complex Coronary Artery Disease After Percutaneous Coronary Intervention: Is the Use of Intravascular Ultrasound an Equalizer of Disease Severity? G Ndrepepa American Journal of Cardiology 206, 345-346, 2023 | | 2023 |
| High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin … K Mayer, G Ndrepepa, M Schroeter, C Emmer, I Bernlochner, S Schüpke, ... Clinical Research in Cardiology 112 (9), 1231-1239, 2023 | 2 | 2023 |
| Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy G Ndrepepa, A Kastrati Journal of Clinical Medicine 12 (17), 5592, 2023 | 14 | 2023 |
| Angiographic coronary no-reflow after primary percutaneous coronary intervention–a combination of an insensitive diagnostic method, inappropriate timing and rushed judgement G Ndrepepa EuroIntervention 19, e368-70, 2023 | 2 | 2023 |
| Coronary No-reflow After Primary Percutaneous Coronary Intervention–Current knowledge on Diagnosis, Pathophysiology, Clinical Impact and Therapy G Ndrepepa, A Kastrati Preprints, 2023 | | 2023 |
| De Ritis ratio and long‐term major cardiovascular adverse events in patients undergoing elective percutaneous coronary intervention G Ndrepepa, S Holdenrieder, A Kastrati European Journal of Clinical Investigation 53 (5), e13942, 2023 | 2 | 2023 |
| Association of De Ritis Ratio with Prognosis in Patients with Coronary Artery Disease and Aminotransferase Activity within and outside the Healthy Values of Reference Range G Ndrepepa, S Cassese, M Scalamogna, S Lahu, A Aytekin, E Xhepa, ... Journal of Clinical Medicine 12 (9), 3174, 2023 | 1 | 2023 |
| P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes G Ndrepepa, A Kastrati European Heart Journal 44 (15), 1371-1373, 2023 | 1 | 2023 |
| Association between platelet count and treatment effect of ticagrelor or prasugrel in patients with acute coronary Syndromes T Koch, S Lahu, JJ Coughlan, S Cassese, F Voll, G Ndrepepa, ... Thrombosis and Haemostasis 123 (04), 464-477, 2023 | 1 | 2023 |
| The effect of a Prasugrel-vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromes A Aytekin, JJ Coughlan, G Ndrepepa, S Cassese, S Lahu, S Kufner, ... European Heart Journal-Cardiovascular Pharmacotherapy 9 (3), 231-239, 2023 | | 2023 |
